mRNA-1647

Cytomegalovirus vaccine (mRNA-1647) · ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for mRNA-1647, covering 2024-01-03 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants. [Phase 2]

See pricing